Selective requirement for Mediator MED23 in Ras-active lung cancer.
about
The Mediator complex and transcription regulationT-cells null for the MED23 subunit of mediator express decreased levels of KLF2 and inefficiently populate the peripheral lymphoid organsLiver Med23 ablation improves glucose and lipid metabolism through modulating FOXO1 activity.Mediator complex dependent regulation of cardiac development and disease.The Mediator complex of Caenorhabditis elegans: insights into the developmental and physiological roles of a conserved transcriptional coregulator.MED30 Regulates the Proliferation and Motility of Gastric Cancer Cells.USP39 Deubiquitinase Is Essential for KRAS Oncogene-driven Cancer.The Mediator subunit MED23 couples H2B mono-ubiquitination to transcriptional control and cell fate determination.ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progressionMEGSA: A Powerful and Flexible Framework for Analyzing Mutual Exclusivity of Tumor Mutations.Comprehensive analysis of the transcriptional profile of the Mediator complex across human cancer types.Mediator subunit 23 overexpression as a novel target for suppressing proliferation and tumorigenesis in hepatocellular carcinoma.Upregulation of mediator MED23 in non-small-cell lung cancer promotes the growth, migration, and metastasis of cancer cells.Downregulation of MED23 promoted the tumorigenecity of esophageal squamous cell carcinoma.SRF Co-factors Control the Balance between Cell Proliferation and Contractility.The mediator subunit Med23 contributes to controlling T-cell activation and prevents autoimmunity.Differing roles for sur-2/MED23 in C. elegans and C. briggsae vulval development.Mutational Heterogeneity of MED23 Gene in Colorectal Cancers.Crystal structure of human Mediator subunit MED23Regulation of the terminal maturation of iNKT cells by mediator complex subunit 23Med23 serves as a gatekeeper of the myeloid potential of hematopoietic stem cells
P2860
Q28299679-A5724CA6-CFA8-46AE-B29E-B4080645AF8AQ28593879-F93FF323-7C18-4CA9-99AF-FA2F3E284B9EQ34289895-74E66E5F-D1FD-4037-8A98-942E969C88C4Q34348002-56D89249-D665-4658-AA8A-C6415BF93853Q35131077-A0EFC66C-88C1-4169-BF2E-8240E09CF54CQ35674474-B22D0E3D-6231-488C-AC2A-98C0E5E756B7Q36268425-EEC1F999-807E-485E-A1CC-C6B334D903C8Q36394676-BCC1CF80-9928-4673-8E2A-50CFE6AD92BEQ36557452-B21EA5AB-631B-4868-A3C0-4D89499FFF13Q36707069-18D84BE5-C16E-4B74-A55F-D71CAAE866D1Q37268937-CF0209E5-60D4-4CC1-9AEE-AF0E96A42EA1Q38909263-F0C257C0-4554-416D-B7B6-656E287FBE59Q38951560-DF299183-0D6D-4230-A6B6-1375DD04008BQ39159028-4989B426-84B0-493C-A6EC-C4E5C9C66868Q39170652-319AD458-1C53-4A22-93E0-FE5FAD50983DQ45065835-2D88B102-B5DD-478A-B9A5-F7E9BDF64BD7Q46414900-84166E4E-FF5E-460B-8619-6205AC61CFA5Q53628489-27180030-B887-4192-B860-AE63FEBBF940Q57842676-32599572-872D-4A87-A02A-9E49807A6819Q58700491-3ED97783-471F-4858-8038-3A8717572A16Q58740792-5CE304AF-91B5-4452-AB48-3D0177D56DDD
P2860
Selective requirement for Mediator MED23 in Ras-active lung cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Selective requirement for Mediator MED23 in Ras-active lung cancer.
@ast
Selective requirement for Mediator MED23 in Ras-active lung cancer.
@en
type
label
Selective requirement for Mediator MED23 in Ras-active lung cancer.
@ast
Selective requirement for Mediator MED23 in Ras-active lung cancer.
@en
prefLabel
Selective requirement for Mediator MED23 in Ras-active lung cancer.
@ast
Selective requirement for Mediator MED23 in Ras-active lung cancer.
@en
P2093
P2860
P356
P1476
Selective requirement for Mediator MED23 in Ras-active lung cancer.
@en
P2093
Hongbin Ji
Yuting Liu
P2860
P304
P356
10.1073/PNAS.1204311109
P407
P577
2012-09-17T00:00:00Z